Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records.

Author: CornishRosie, HickmanMatthew, MacleodJohn, MarsdenJohn, MillarTim, SteerColin, StrangJohn, TillingKate

Paper Details 
Original Abstract of the Article :
Patients with opioid dependency prescribed opioid agonist treatment (OAT) may also be prescribed sedative drugs. This may increase mortality risk but may also increase treatment duration, with overall benefit. We hypothesised that prescription of benzodiazepines in patients receiving OAT would incre...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879111/

データ提供:米国国立医学図書館(NLM)

Benzodiazepines, Z-Drugs, and Gabapentinoids: Navigating the Desert of Opioid Agonist Treatment

The desert of opioid agonist treatment is a complex and challenging landscape, where patients often face a variety of co-occurring conditions. This study investigates the potential risks associated with prescribing benzodiazepines, z-drugs, and gabapentinoids to patients receiving opioid agonist treatment (OAT).

The researchers found that prescription of benzodiazepines in patients receiving OAT was associated with an increased risk of mortality, even when considering the potential benefits of increased treatment duration. It's like navigating a desert with a compass that sometimes points in the wrong direction.

The Importance of Careful Medication Management

This study highlights the importance of careful medication management in patients receiving OAT. The researchers found that benzodiazepine prescription was associated with an increased risk of mortality, suggesting that these drugs should be used with caution in this population. It's a reminder that even seemingly safe medications can have unexpected consequences when used in combination with other drugs.

Navigating the Risks and Benefits of OAT

This study provides valuable insights into the risks and benefits of OAT. It's a reminder that we need to carefully weigh the potential benefits of medication against the potential risks, especially when treating complex conditions.

Dr.Camel's Conclusion

This study underscores the importance of careful medication management in patients receiving OAT. It suggests that benzodiazepines should be used with caution in this population and that careful monitoring is essential to minimize the risk of adverse outcomes.

Date :
  1. Date Completed 2020-02-07
  2. Date Revised 2021-01-10
Further Info :

Pubmed ID

31770388

DOI: Digital Object Identifier

PMC6879111

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.